ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,555.74
-0.16%
US Tech 100
19,020.40
-1.06%
Dow Jones
40,358.09
-0.14%
Brent Oil
80.775
0.00%
Bitcoin
66,251.15
0.50%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Blue Owl Capital Corporation III (OBDE) Quote

Blue Owl Capital Corporation III

Blue Owl Capital Corporation III (OBDE)

NYSE
14.59
-0.10
(-0.68%)
Closed July 23 4:00PM
Delayed by 15 minutes
14.59
0.00
( 0.00% )
Pre Market: 4:05AM
Delayed by 15 minutes

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Key stats and details

Current Price
14.59
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
14.23 52 Week Range 16.80
Market Cap
1.8B
Previous Close
14.59
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
114,951
Shares Outstanding
123,356,823
Dividend Yield
9.60%
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About Blue Owl Capital Corporation III

Blue Owl Capital Corporation (NYSE: OBDC) is a specialty finance and business development company (BDC) that provides direct lending solutions to U.S. middle-market companies. Our portfolio consists of predominantly senior secured loans that are directly originated by Blue Owl Credit¿s team of inves... Blue Owl Capital Corporation (NYSE: OBDC) is a specialty finance and business development company (BDC) that provides direct lending solutions to U.S. middle-market companies. Our portfolio consists of predominantly senior secured loans that are directly originated by Blue Owl Credit¿s team of investment professionals. Show more

Sector
Finance Services
Industry
Finance Services
Website
www.blueowlcapitalcorporationiii.com
Headquarters
Chevy Chase, Maryland, USA
Founded
1970
Blue Owl Capital Corporation III is listed in the Finance Services sector of the New York Stock Exchange with ticker OBDE. The last closing price for Blue Owl Capital Corpora... was $14.59. Over the last year, Blue Owl Capital Corpora... shares have traded in a share price range of $ 14.23 to $ 16.80.

Blue Owl Capital Corpora... currently has 123,356,823 shares outstanding. The market capitalization of Blue Owl Capital Corpora... is $1.80 billion.

OBDE Latest News

More News

Blue Owl Capital Corporation III Schedules Earnings Release and Quarterly Earnings Call to Discuss its Second Quarter Ended June 30, 2024 Financial Results

Blue Owl Capital Corporation III Schedules Earnings Release and Quarterly Earnings Call to Discuss its Second Quarter Ended June 30, 2024 Financial Results PR Newswire NEW YORK, July 3, 2024 NEW...

July 03 2024
PR Newswire (US)

Form 8-K - Current report

May 29 2024
Edgar (US Regulatory)

Form 40-17G - Fidelity Bond [Rule 17G-1(g)]

May 23 2024
Edgar (US Regulatory)

Form 8-K - Current report

May 08 2024
Edgar (US Regulatory)

Blue Owl Capital Corporation III Reports First Quarter Net Investment Income Per Share of $0.39 and NAV Per Share of $15.65

Blue Owl Capital Corporation III Reports First Quarter Net Investment Income Per Share of $0.39 and NAV Per Share of $15.65 PR Newswire NEW YORK, May 8, 2024 NEW YORK, May 8, 2024 /PRNewswire/...

May 08 2024
PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 08 2024
Edgar (US Regulatory)

Blue Owl Capital Corporation III Schedules Earnings Release and Quarterly Earnings Call to Discuss its First Quarter Ended March 31, 2024 Financial Results

Blue Owl Capital Corporation III Schedules Earnings Release and Quarterly Earnings Call to Discuss its First Quarter Ended March 31, 2024 Financial Results PR Newswire NEW YORK, April 8, 2024 NEW...

April 08 2024
PR Newswire (US)

Blue Owl Capital Corporation III Reports Full Year Results and Fourth Quarter Net Investment Income Per Share of $0.58 and NAV Per Share of $15.56

Blue Owl Capital Corporation III Reports Full Year Results and Fourth Quarter Net Investment Income Per Share of $0.58 and NAV Per Share of $15.56 PR Newswire NEW YORK, Feb. 21, 2024 NEW YORK...

February 21 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.51-3.3774834437115.115.114.4810619614.74674244CS
4-0.29-1.9489247311814.8815.214.4820345614.97377718CS
12-0.42-2.7981345769515.0116.588514.4811495115.07761165CS
26-0.61-4.0131578947415.216.814.237566915.06192391CS
52-0.61-4.0131578947415.216.814.237566915.06192391CS
156-0.61-4.0131578947415.216.814.237566915.06192391CS
260-0.61-4.0131578947415.216.814.237566915.06192391CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 2.03
(97.09%)
596.27k
ALLRAllarity Therapeutics Inc
$ 0.2997
(80.00%)
6.85M
RGCRegencell Bioscience Holdings Ltd
$ 23.00
(53.74%)
62.72k
NIVFNewGenIvf Group Ltd
$ 1.09
(25.16%)
466.15k
KITTNauticus Robotics Inc
$ 3.96
(21.10%)
48.34k
CONNConns Inc
$ 0.261
(-48.52%)
38.32k
VSTMVerastem Inc
$ 2.80
(-22.01%)
1.53k
ATPCAgape ATP Corporation
$ 0.1704
(-20.74%)
43.53k
ALPPAlpine 4 Holdings Inc
$ 0.4899
(-18.34%)
15.57k
SLRXSalarius Pharmaceuticals Inc
$ 2.16
(-17.24%)
4.6k
ALLRAllarity Therapeutics Inc
$ 0.2997
(80.00%)
6.85M
SLNASelina Hospitality PLC
$ 0.0276
(6.15%)
2.44M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 11.57
(-15.55%)
703.91k
NUZENuZee Inc
$ 2.03
(97.09%)
597.16k
NIVFNewGenIvf Group Ltd
$ 1.09
(25.16%)
466.15k

Discussion

View Full Feed
chaostrader chaostrader 3 minutes ago
When will PDMI have a business operation
PDMI
fuagf fuagf 5 minutes ago
Yep, was good to see back when Biden finally got older Americans
something like we oldies in Australia have had the benefit of for years.
Handlamera Handlamera 5 minutes ago
Thank you for info Laxmi!
I really hope that you now can give yourself and your heart time to get well!
J
ITUP
Margin Buu Margin Buu 10 minutes ago
One of the biggest FUD tactics has been around the timeframe of this approval. There have been 1000 posts by nefarious actors just trying to convince us that the 150-day review pathway (requested by the company) was in business days when the review clock has always been CALENDAR DAYS. Not only is t
NWBO
chicks0123 chicks0123 12 minutes ago
Good morning CLNVERS
CLNV
urge2surge urge2surge 14 minutes ago
Copied and posted word for word.
FDCT
dirkv dirkv 15 minutes ago
Theravet (BE0974387194) Euronext Growth Paris et Bruxelles : 0.278
52w: 0.278 – 2.4
https://www.thera.vet/en/home

https://www.theravet-finances.com/images/202404_Theravet_Company_Presentation_Competition_Sport_Horses.pdf

their products:
https://bioc
dirkv dirkv 15 minutes ago
Theravet (BE0974387194) Euronext Growth Paris et Bruxelles : 0.278
52w: 0.278 – 2.4
https://www.thera.vet/en/home

https://www.theravet-finances.com/images/202404_Theravet_Company_Presentation_Competition_Sport_Horses.pdf

their products:
https://bioc
manfromjax manfromjax 17 minutes ago
WOW, am I going to be happy that I picked up 2000 more shares of ALLR at .17!!!
average is now .32.
Was up to .30 as I sit here in Riga Latvia.
ALLR
ShadowDiviner72 ShadowDiviner72 19 minutes ago
Shorts can say whatever they want, but why is the cost to borrow fee decreasing rapidly?

In 10 trading days from 96% to 9%

Apparently the demand for short shares is decreasing quickly
MAXN
MrLWLG101 MrLWLG101 21 minutes ago
The news about the appointment of Yves LeMaitre, a renowned and respected figure in the industry and business, acts as a magnet for short-sellers. I see this more in terms of "defamation and slander" against him and the entire BOD of LWLG, without thorough reasons and evidence. The moderators should
LWLG
SkeBallLarry SkeBallLarry 22 minutes ago
Graceland (from The Concert in Hyde Park >

https://youtu.be/0VTcBO4q5kY
SkeBallLarry SkeBallLarry 22 minutes ago
Graceland (from The Concert in Hyde Park >

https://youtu.be/0VTcBO4q5kY
SkeBallLarry SkeBallLarry 23 minutes ago
BreakTime ~ Graceland (from The Concert in Hyde Park >

https://youtu.be/0VTcBO4q5kY
palaypu0406 palaypu0406 23 minutes ago
whenever large wires that too international wires transfer in, or anytime if there is a larger inward (even domestic) with regular balances not anywhere near to the size of the funds coming in, bank does keep the funds on hold and release within the defined date.
ITUP
1hunglo 1hunglo 25 minutes ago
AGREED.
RDGL
palaypu0406 palaypu0406 27 minutes ago
Dear Snow and all (I am addressing Snow first as he is the eldest among the group),
I am very happy to share that we have money availability on the 7/29/2024) -- This is one year of burn -- facing so many challenges, insults, humiliation and spits on face. Despite that - we never let our spi
ITUP
Margin Buu Margin Buu 31 minutes ago
Thanks for pointing out Leg-ends hypocrisy. He’s a spreader of FUD and not very good at it.
NWBO
Jack Torrance Jack Torrance 34 minutes ago
I personally think 80%.
MNMD
CaptainObvious CaptainObvious 38 minutes ago
"The reality about this stock is nobody knows anything....

...something I will bet a lot on is that the stock will not get above $1"
NWBO
Capt_Smith77 Capt_Smith77 1 hour ago
I'll believe in their backing of G42 when it doesn't amount to diluting shareholders, and there's an actual appreciation in the stock price. To date, the company's financing has done nothing but reduce shareholder value.

Now on a more positive note, at least we haven't seen any recen
VRSSF

Your Recent History

NYSE
OBDE
Blue Owl Capital Corpora...
KUCN
UBXTUSDT
UpBots
EU
N392S
N392S
COIN
IDSKRW
Space ID
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved